Natco Pharma zooms 20% as partner's injection gets USFDA nod
The stock soared 20 per cent to Rs 954.35 -- its highest trading permissible limit for the day -- on the BSE.
Oct 04, 2017, 12:44 PM IST
Natco Pharma shares extend fall; down 5% on USFDA observations
Continuing to fall for the second consecutive day, shares of Natco Pharma fell by nearly 5 percent today, after the company received 483 observations from the USFDA after inspection of its two facilities.
Mar 29, 2016, 14:22 PM IST
US court finds Copaxone patent invalid again: Natco Pharma
The Natco stock was trading at Rs 2,187.05, up 5.33 percent, on BSE at 1513 hours.
Jun 19, 2015, 15:34 PM IST
Natco Pharma mulls hiking FII limit, looks to raise funds
Natco Pharma plans to increase the limit of foreign institutional investors (FIIs) to 49 percent as it looks to raise more funds through issuing shares or convertible securities.
May 12, 2015, 13:48 PM IST
